Clinical Trial Update: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of deferasirox for iron overload due to transfusions in patients with hematologic malignancies; study status completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia in Remission
• Acute Myeloid Leukemia in Remission
• Acute Myeloid Leukemia with
• Acute Myeloid Leukemia with 11q23 Abnormalities
• Acute Myeloid Leukemia with Del
• Acute Myeloid Leukemia with Inv
• Undifferentiated Leukemia

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Status: COMPLETED | Results posted: 2013-11-27